The findings that PTX3 promotes long‐term recovery of cerebral blood flow, angiogenesis, and neuronal viability after cerebral ischemia suggest the potential for PTX3 as a promising therapeutic target of clinical relevance (Rajkovic et al., 2018). This evidence concerns the gene PTX3 and brain ischemia.